Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025 - Yahoo Finance

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025  Yahoo Finance

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025 - Yahoo Finance

Click here to get full coverage on OPKO Health's Russell 2000 Defensive Index Inclusion: A Catalyst for Strategic Revaluation - AInvest

OPKO Health's Russell 2000 Defensive Index Inclusion: A Catalyst for Strategic Revaluation  AInvest

OPKO Health's Russell 2000 Defensive Index Inclusion: A Catalyst for Strategic Revaluation - AInvest

Click here to get full coverage on OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting - OPKO Health, Inc.

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting  OPKO Health, Inc.

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting - OPKO Health, Inc.

Click here to get full coverage on First-Ever Oral GLP-1/Glucagon Dual Therapy for Obesity: OPKO's Game-Changing Data Coming to ENDO 2025 - Stock Titan

First-Ever Oral GLP-1/Glucagon Dual Therapy for Obesity: OPKO's Game-Changing Data Coming to ENDO 2025  Stock Titan

First-Ever Oral GLP-1/Glucagon Dual Therapy for Obesity: OPKO's Game-Changing Data Coming to ENDO 2025 - Stock Titan

Click here to get full coverage on Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PR Newswire

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses  PR Newswire

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PR Newswire

Click here to get full coverage on What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st

What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You  simplywall.st

What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st

Click here to get full coverage on Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK)  MarketBeat

Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Click here to get full coverage on Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT - Yahoo Finance

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT  Yahoo Finance

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT - Yahoo Finance

Click here to get full coverage on OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - OPKO Health, Inc.

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results  OPKO Health, Inc.

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - OPKO Health, Inc.

Click here to get full coverage on OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...  Yahoo Finance

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance

Click here to get full coverage on Analyst Estimates: Here's What Brokers Think Of OPKO Health, Inc. (NASDAQ:OPK) After Its Annual Report - Yahoo Finance

Analyst Estimates: Here's What Brokers Think Of OPKO Health, Inc. (NASDAQ:OPK) After Its Annual Report  Yahoo Finance

Analyst Estimates: Here's What Brokers Think Of OPKO Health, Inc. (NASDAQ:OPK) After Its Annual Report - Yahoo Finance

Click here to get full coverage on Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy? - Yahoo Finance

Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?  Yahoo Finance

Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy? - Yahoo Finance

Click here to get full coverage on Is OPKO Health, Inc. (OPK) The Best Stock Under $3 to Buy Now? - Yahoo Finance

Is OPKO Health, Inc. (OPK) The Best Stock Under $3 to Buy Now?  Yahoo Finance

Is OPKO Health, Inc. (OPK) The Best Stock Under $3 to Buy Now? - Yahoo Finance

Click here to get full coverage on OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates  Yahoo Finance

OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Click here to get full coverage on Countdown to OPKO Health (OPK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance

Countdown to OPKO Health (OPK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS  Yahoo Finance

Countdown to OPKO Health (OPK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance

Click here to get full coverage on OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say  Yahoo Finance

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

Click here to get full coverage on OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt  simplywall.st

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st

Click here to get full coverage on Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround - Yahoo Finance

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround  Yahoo Finance

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround - Yahoo Finance

Click here to get full coverage on Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance

Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss  Yahoo Finance

Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance

Click here to get full coverage on Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025 - TipRanks

Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025  TipRanks

Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025 - TipRanks

Click here to get full coverage on OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential  Yahoo Finance

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance

Click here to get full coverage on Entera Bio, Opko Health announce new in vivo data for OPK-88006 - TipRanks

Entera Bio, Opko Health announce new in vivo data for OPK-88006  TipRanks

Entera Bio, Opko Health announce new in vivo data for OPK-88006 - TipRanks

Click here to get full coverage on ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - Yahoo Finance

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data  Yahoo Finance

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - Yahoo Finance

Click here to get full coverage on Here's Why You Should Retain OPKO Health Stock in Your Portfolio - Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio  Yahoo Finance

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - Yahoo Finance

Click here to get full coverage on OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Zacks Investment Research

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands  Zacks Investment Research

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Zacks Investment Research

Click here to get full coverage on OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewswire

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program  GlobeNewswire

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewswire

Click here to get full coverage on OPKO Health (OPK) Beats Q4 Earnings and Revenue Estimates - Nasdaq

OPKO Health (OPK) Beats Q4 Earnings and Revenue Estimates  Nasdaq

OPKO Health (OPK) Beats Q4 Earnings and Revenue Estimates - Nasdaq

Click here to get full coverage on OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK) - Seeking Alpha

OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK)  Seeking Alpha

OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK) - Seeking Alpha

Click here to get full coverage on Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - PR Newswire

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health  PR Newswire

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - PR Newswire

Click here to get full coverage on Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera's Game-Changing Tablet Data Heads to ENDO 2025 - Stock Titan

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera's Game-Changing Tablet Data Heads to ENDO 2025  Stock Titan

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera's Game-Changing Tablet Data Heads to ENDO 2025 - Stock Titan

Click here to get full coverage on OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus

OPKO Health (OPK) Rises with Promising Oncology Developments  GuruFocus

OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus

Click here to get full coverage on OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - OPKO Health, Inc.

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025  OPKO Health, Inc.

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - OPKO Health, Inc.

Click here to get full coverage on Here's Why You Should Retain OPKO Health Stock in Your Portfolio - TradingView

Here's Why You Should Retain OPKO Health Stock in Your Portfolio  TradingView

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - TradingView

Click here to get full coverage on OPKO Health to Participate in Two Upcoming Investor Conferences - OPKO Health, Inc.

OPKO Health to Participate in Two Upcoming Investor Conferences  OPKO Health, Inc.

OPKO Health to Participate in Two Upcoming Investor Conferences - OPKO Health, Inc.

Click here to get full coverage on OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders - GlobeNewswire

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders  GlobeNewswire

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders - GlobeNewswire

Click here to get full coverage on Military-Industrial Complex and Sanctions Impact - Riddle Russia

Military-Industrial Complex and Sanctions Impact  Riddle Russia

Military-Industrial Complex and Sanctions Impact - Riddle Russia

Click here to get full coverage on OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - GlobeNewswire

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results  GlobeNewswire

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - GlobeNewswire

Click here to get full coverage on OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 - OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025  OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 - OPKO Health, Inc.

Click here to get full coverage on OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - Zacks Investment Research

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands  Zacks Investment Research

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - Zacks Investment Research

Click here to get full coverage on ModeX assembles advisory board for antibody development - Investing.com

ModeX assembles advisory board for antibody development  Investing.com

ModeX assembles advisory board for antibody development - Investing.com

Click here to get full coverage on Chairman & CEO of OPKO Health Phillip Frost Buys More Stock - Yahoo Finance

Chairman & CEO of OPKO Health Phillip Frost Buys More Stock  Yahoo Finance

Chairman & CEO of OPKO Health Phillip Frost Buys More Stock - Yahoo Finance

Click here to get full coverage on Opko Health Grants Stock Options and Bonuses - TipRanks

Opko Health Grants Stock Options and Bonuses  TipRanks

Opko Health Grants Stock Options and Bonuses - TipRanks

Click here to get full coverage on Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance

Labcorp is Set to Acquire Select Assets of BioReference Health of OPK  Yahoo Finance

Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance

Click here to get full coverage on Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha

Labcorp stock gains on deal to buy OPKO assets (LH:NYSE)  Seeking Alpha

Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha

Click here to get full coverage on OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - AInvest

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential  AInvest

OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - AInvest

Click here to get full coverage on OPKO HEALTH, INC. SEC 10-K Report - TradingView

OPKO HEALTH, INC. SEC 10-K Report  TradingView

OPKO HEALTH, INC. SEC 10-K Report - TradingView

Click here to get full coverage on Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More. - Barron's

Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More.  Barron's

Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More. - Barron's

Click here to get full coverage on Opko health CEO Phillip Frost buys $164,850 in stock - Investing.com

Opko health CEO Phillip Frost buys $164,850 in stock  Investing.com

Opko health CEO Phillip Frost buys $164,850 in stock - Investing.com

Click here to get full coverage on Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com

Earnings call transcript: Opko Health misses Q1 2025 earnings forecast  Investing.com

Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com

Click here to get full coverage on OPKO and Entera partner to develop obesity pill - Reuters

OPKO and Entera partner to develop obesity pill  Reuters

OPKO and Entera partner to develop obesity pill - Reuters

Click here to get full coverage on OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - GlobeNewswire

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025  GlobeNewswire

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - GlobeNewswire

Click here to get full coverage on Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com

Opko Health earnings missed by $0.01, revenue fell short of estimates  Investing.com

Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com

Click here to get full coverage on OPK and Patrick Boamah: Why these two NPP MPs are championing release of Oquaye Report - GhanaWeb

OPK and Patrick Boamah: Why these two NPP MPs are championing release of Oquaye Report  GhanaWeb

OPK and Patrick Boamah: Why these two NPP MPs are championing release of Oquaye Report - GhanaWeb

Click here to get full coverage on Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - Stock Titan

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates  Stock Titan

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - Stock Titan

Click here to get full coverage on OPKO Health’s ModeX Therapeutics Announces Formation of - GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Formation of  GlobeNewswire

Opko Health Inc (OPK)

Price Chart

Key Statistics

Technicals

About OPK

Latest News

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025 - Yahoo Finance

OPKO Health's Russell 2000 Defensive Index Inclusion: A Catalyst for Strategic Revaluation - AInvest

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting - OPKO Health, Inc.

Advanced Charts

Top Gainers

Top Losers